Impact on Quality during In-Use Preparation of an Antibody Drug Conjugate with Eight Different Closed System Transfer Device Brands Léa SorretWei Han TanMatthias Winzer Research Article 15 May 2024 Article: 61
Anti-Drug Antibody Incidence Comparison of Therapeutic Proteins Administered Via Subcutaneous vs. Intravenous Route Jacob FeldermanLila RamaiahYing Chen Research Article 10 May 2024 Article: 60
Impact of Obesity on Hepatic Drug Clearance: What are the Influential Variables? Tan ZhangElisa A. M. CalvierCatherijne A. J. Knibbe Research Article Open access 09 May 2024 Article: 59
Correction: Group-by-Treatment Interaction Effects in Comparative Bioavailability Studies Helmut SchützDivan A. BurgerMichael Tomashevskiy Correction Open access 06 May 2024 Article: 58
Prediction of Individual Disease Progression Including Parameter Uncertainty in Rare Neurodegenerative Diseases: The Example of Autosomal-Recessive Spastic Ataxia Charlevoix Saguenay (ARSACS) Niels HendrickxFrance MentréEmmanuelle Comets Research Article Open access 30 April 2024 Article: 57
Pharmacokinetic Models for Inhaled Fluticasone Propionate and Salmeterol Xinafoate to Quantify Batch-to-Batch Variability Shuhui LiKairui FengJogarao V. S. Gobburu Research Article 26 April 2024 Article: 56
Application of Advanced Modeling Approaches Supporting Generic Product Development Under GDUFA for Fiscal Year 2023 Eleftheria TsakalozouYuqing GongLiang Zhao Editorial 24 April 2024 Article: 55
Effect of Food Composition on the PK of Isoniazid Quantitatively Explained Using Physiologically Based Biopharmaceutics Modeling Xavier J. H. PepinSandra Suarez-Sharp Research Article 24 April 2024 Article: 54
Uncertainty Computation at Finite Distance in Nonlinear Mixed Effects Models—a New Method Based on Metropolis-Hastings Algorithm Mélanie GuhlJulie BertrandEmmanuelle Comets Research Article 23 April 2024 Article: 53
Third Generation Solid Dispersion-Based Formulation of Novel Anti-Tubercular Agent Exhibited Improvement in Solubility, Dissolution and Biological Activity Gourav PaudwalRigzin DolkarPrem N. Gupta Research Article 22 April 2024 Article: 52
Implementation of a Three-Way Comparability Assessment for a Bioanalytical Anti-Drug Antibody Method Rosanna S. KwokIhsan NijemRobert Hendricks Research Article Open access 18 April 2024 Article: 51
Group-by-Treatment Interaction Effects in Comparative Bioavailability Studies Helmut SchützDivan A. BurgerMichael Tomashevskiy Research Article Open access 17 April 2024 Article: 50
Preliminary Investigation of a Rapid and Feasible Therapeutic Drug Monitoring Method for the Real-Time Estimation of Blood Pazopanib Concentrations Masaru KatoShinichi MaruyamaHiroshi Kanno Research Article 15 April 2024 Article: 48
Ginsenoside Rg1 Alleviates Sepsis-Induced Acute Lung Injury by Reducing FBXO3 Stability in an m6A-Dependent Manner to Activate PGC-1α/Nrf2 Signaling Pathway Rong LiuQiang WangJiafei Lu Research Article 15 April 2024 Article: 47
Bile Acid–Targeted Hyaluronic Acid Nanoparticles for Enhanced Oral Absorption of Deferoxamine Elizabeth Oladoyin AgboluajeShuolin CuiMay P. Xiong Research Article 12 April 2024 Article: 46
Leveraging Modeling and Simulation to Enhance the Efficiency of Bioequivalence Approaches for Generic Drugs: Highlights from the 2023 Generic Drug Science and Research Initiatives Public Workshop Arindom PalFang WuLanyan Fang Meeting Report 08 April 2024 Article: 45
Mechanistic Modeling of In Vitro Biopharmaceutic Data for a Weak Acid Drug: A Pathway Towards Deriving Fundamental Parameters for Physiologically Based Biopharmaceutic Modeling Venkata Krishna KowthavarapuNitin Bharat CharbeRodrigo Cristofoletti Tutorial 04 April 2024 Article: 44
Oral Drug Product Administration via Enteral Feeding Tubes: In Vitro Testing Selina WilsonJulianne FarabaughKaren Thompson Commentary 04 April 2024 Article: 43
LC–MS Characterization and Stability Assessment Elucidate Correlation Between Charge Variant Composition and Degradation of Monoclonal Antibody Therapeutics Himanshu MalaniAnuj ShrivastavaAnurag S. Rathore Research Article 03 April 2024 Article: 42
Cross-Reactive Polyclonal Antibodies Raised Against GalNAc-Conjugated siRNA Recognize Mostly the GalNAc Moiety Kimberly K. BallmanVictoria L. PeekYi Wen Research Article 03 April 2024 Article: 41
Predicting the Stability of Lyophilized Human Serum Albumin Formulations Containing Sucrose and Trehalose Using Solid-State NMR Spectroscopy: Effect of Storage Temperature on 1H T1 Relaxation Times Ashley Lay-FortenberyCole W. TowerEric J. Munson Research Article Open access 03 April 2024 Article: 40
PmWebSpec: An Application to Create and Manage CDISC-Compliant Pharmacometric Analysis Dataset Specifications Lu ChenErin DombrowskyNeelima Thanneer Tutorial Open access 03 April 2024 Article: 39
Characterization and Applications of Permeabilized Hepatocytes in Drug Discovery Sam ZhangChristine C. OrozcoLi Di Research Article 28 March 2024 Article: 38
Development and Validation of a Cell-Based Binding Neutralizing Antibody Assay for an Antibody–Drug Conjugate Weifeng XuNazneen BanoRoy Helmy Research Article 28 March 2024 Article: 37
Novel Multiplexed High Throughput Screening of Selective Inhibitors for Drug-Metabolizing Enzymes Using Human Hepatocytes Jianhua LiuDaria VernikovskayaLi Di Research Article 28 March 2024 Article: 36
State of the Art of Silica Nanoparticles: An Overview on Biodistribution and Preclinical Toxicity Studies Joshua YuNirnoy DanXiuling Lu Review Article-theme 21 March 2024 Article: 35